Effects of selected repeated intravitreal chemotherapeutic agents. 1985

J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg

The toxic effects of repeated intravitreal injections of selected chemotherapeutic agents were studied in female albino rabbits. Three groups of eyes participated in each therapeutic regimen. Agents studied were doxorubicin (dox), 3 and 5 micrograms; 5-fluorouracil (5-FU), 0.375 and 1.0 mg; bleomycin (bleo), 15 micrograms; thiotepa (thio), 12 micrograms; etoposide (VP-16), 150 micrograms; and methotrexate (MTX), 600 mic. Toxicity was evaluated using electroretinography (ERG) in 66% and histopathology in 100% of eyes 5 weeks following the initial injection and at least 2 weeks after the final injection of each series. Eyes receiving 2 doses of dox 3 micrograms showed no toxicity. Eyes receiving 3 or more doses of dox 3 micrograms and those treated with 2 or more doses of dox 5 demonstrated toxicity proportional to the number of doses received. Eyes treated with 5-FU 0.375 or 1.0 mg showed no toxic reaction. Successive intravitreal injections of 5-FU, 0.375 mg and dox 5 micrograms, and 5-FU, dox, and bleo produced no toxicity. Eyes treated with successive intravitreal injections of 5-FU, dox, bleo, and thio displayed decreased ERG response. The addition of VP-16 and MTX resulted in further loss of ERG response and more severe histologic retinal changes.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D002386 Cataract Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed) Cataract, Membranous,Lens Opacities,Pseudoaphakia,Cataracts,Cataracts, Membranous,Lens Opacity,Membranous Cataract,Membranous Cataracts,Opacities, Lens,Opacity, Lens,Pseudoaphakias
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004596 Electroretinography Recording of electric potentials in the retina after stimulation by light. Electroretinographies
D005123 Eye The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light. Eyes
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000963 Antimetabolites Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) Antimetabolite

Related Publications

J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
January 1964, Acta ophthalmologica,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
January 1978, Annual review of microbiology,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
July 1982, Die Pharmazie,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
January 1994, Urological research,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
February 1983, Cancer treatment reports,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
December 2003, Archivos de la Sociedad Espanola de Oftalmologia,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
January 1970, Duodecim; laaketieteellinen aikakauskirja,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
April 2022, Clinical journal of oncology nursing,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
December 1973, Biometrics,
J Vernot, and G A Peyman, and R Gailitis, and R Fiscella, and M Woodhouse, and D Weinberg
August 1975, Comprehensive therapy,
Copied contents to your clipboard!